Status:
WITHDRAWN
COVID-19 Vaccine For Indirect Protection
Lead Sponsor:
McMaster University
Collaborating Sponsors:
University of Alberta
University of Saskatchewan
Conditions:
Vaccine Preventable Disease
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The primary objective of this study is to test whether vaccinating adults ≥18 years in Hutterite colonies with mRNA-1273 (Moderna COVID-19) vaccine as compared to control (usual care) can prevent RT-P...
Detailed Description
Despite the efficacy that has been demonstrated in Phase III randomized controls trials of mRNA COVID-19 vaccines, a critical question that remains unanswered is whether mRNA vaccines lead to herd imm...
Eligibility Criteria
Inclusion
- Group A: Anyone other than the adults aged ≥18 years who are vaccinated
- Individuals under the age of 18
- Individuals with a contraindication to study vaccines
- Those not willing to be vaccinated but consent to follow up
Exclusion
- \- There are no exclusion criteria for this category of participants:
- Group B: Adults aged 18 years or older, who will be vaccinated as part of the intervention.
Key Trial Info
Start Date :
April 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04818736
Start Date
April 15 2021
End Date
December 1 2021
Last Update
May 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McMaster University
Hamilton, Ontario, Canada, L8S 4K1